Phenotypic Profile and Molecular Mechanism of Resistance in Carbapenemase-producing Enterobacterales and Pseudomonas Aeruginosa Isolates From Brazilian Hospitals: Implications for the Introduction of IMIPENEM-RELEBACTAM
Clinical trial NCT05285046 · UNKNOWN
Trial details
- NCT number
- NCT05285046
- Sponsor
- D'Or Institute for Research and Education
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-04-01
- Primary completion
- 2022-10-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.